The Antitumor Properties of Cannabis: Preclinical Evidence
Dr. Cristina Sanchez, a biochemist with over 20 years of experience as a cannabinoid researcher, outlines the preclinical evidence of cannabinoids on different types of cancer.
This author has yet to write their bio.
Meanwhile lets just say that we are proud Nikhil Jain contributed a whooping 42 entries.
Dr. Cristina Sanchez, a biochemist with over 20 years of experience as a cannabinoid researcher, outlines the preclinical evidence of cannabinoids on different types of cancer.
Dr. Arno Hazekamp discusses the intricacies of the Sativa/Indica debate. He describes metabolic characterists of cannabis constituents and the characteristics of hybrids. Originally recorded at the SCC Quarterly Meeting in March of 2018.
Dr. Kirsten Muller-Vahl, is a physician specializing in neurology and psychiatry, is the world’s authority on cannabis and Tourette’s syndrome. She presents “Tourette Syndrome: Clinical presentation, underlying pathology and treatment options” at the February SCC Quarterly Meeting on January 4, 2018.
Dr. David (Dedi) Meiri presents on “Laboratory of Cancer Biology and Cannabinoid Research” at the SCC Quarterly Meeting on September 17, 2017
The SCC provides continuing education for ourselves, patients, and colleagues about the medical use of cannabis and best practices in clinical care.
Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information.